Learn more

NOVARTIS CONSUMER HEALTH SA

Overview
  • Total Patents
    171
  • GoodIP Patent Rank
    78,545
  • Filing trend
    ⇩ 20.0%
About

NOVARTIS CONSUMER HEALTH SA has a total of 171 patent applications. It decreased the IP activity by 20.0%. Its first patent ever was published in 1996. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United Kingdom. Its main competitors in its focus markets pharmaceuticals, medical technology and packaging and shipping are SERRANO GIL DANIEL, EPIGENESIS PHARMACEUTICALS LLC and LEOPOLDO DE JESUS ESPINOSA ABD.

Patent filings per year

Chart showing NOVARTIS CONSUMER HEALTH SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Steiger Michel 24
#2 Ancerewicz Jacek 23
#3 Schumann Phyllis 23
#4 Sallin Dominique 23
#5 Kienzler Jean-Luc 22
#6 Schmid Beat 17
#7 Larnier Catherine 14
#8 Tschollar Werner 14
#9 Rault Isabelle 14
#10 Marzano Giovanna 13

Latest patents

Publication Filing date Title
GB201718368D0 Novel composition
GB201718365D0 Novel composition
GB201718363D0 Novel composition
GB201718367D0 Novel composition
WO2017212422A1 Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions
WO2016120787A1 Oral n-acetylcysteine in the treatment of upper respiratory tract infections and symptoms
GB201515354D0 Novel Device
US2015265713A1 Phenylephrine formulations with improved stability
EP2480212A1 Oral pharmaceutical composition comprising diclofenac
GB0605997D0 Containment For Supplying Individual Pouches
WO2005079603A1 Dietary fiber composition
WO2005075320A1 Casing for a blister package
EP1667664A1 Coated tablets of diclofenac
AU2004262934A1 Topical composition comprising terbinafine and hydrocortisone
GB0417909D0 Drop preparations
GB0325604D0 Coated tablets
GB0322371D0 Coated tablets
WO2004017998A2 Topical emulsion- gel composition comprising diclofenac sodium
WO2004000272A1 Nasal compositions comprising a mucopolysaccharide and propylene glycol
GB0218994D0 Oral pharmaceutical compositions